{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:44:39Z","timestamp":1791290679734,"version":"4.3.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Fibromyalgia (FM) is a common rheumatic disorder characterized by chronic, widespread pain associated with several not painful symptoms. The contribution of gender to the manifestation of the disease may influence the higher prevalence of FM among women. In spite of this, how patients\u2019 gender influences the clinical manifestation of FM is still not well understood. The frequent association with neuropsychiatric symptoms raised the attention on the role of neurotrophins, including the brain-derived neurotrophic factor (BDNF) as potential biomarkers of the condition. Aims of the study were to evaluate the influence of gender on clinical manifestations and to investigate BDNF serum levels as a potential biomarker of FM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We consecutively enrolled 201 adult patients of both sexes diagnosed with FM. For each patient, we collected clinical and clinimetric data and, in a subgroup of 40 patients, we measured serum BDNF levels. BDNF levels have been measured also in 40 matched healthy controls (HC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Several symptoms were significantly higher in women compared with men, including pain, fatigue, memory problems, tenderness, balance problems and sensitivity to environmental stimuli. On the contrary, men reported a significant higher frequency of coexisting depressive symptoms. BDNF levels were significantly lower in FM patients compared with HC, discriminating with good accuracy the condition.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Gender influences FM clinical manifestations, with a higher prevalence of pain, fatigue and other common FM symptoms among women while higher frequency of neuropsychiatric symptoms among men. BDNF offers promises as a potential biomarker of the disease.<jats:table-wrap><jats:table><jats:tbody>\n                      <jats:tr>\n                        <jats:td colspan=\"2\"><jats:bold>Key Points<\/jats:bold><jats:italic>\u2022 Gender-related differences in the clinical manifestations of FM may contribute to the higher prevalence of FM among females. Indeed, women show higher levels of pain and symptoms traditionally associated to FM, which are evaluated to establish the diagnosis according to the clinical criteria.<\/jats:italic><jats:italic>\u2022 The new insights into the pathogenesis of the disease raised the attention on the role of brain mediators in FM. Among these, BNDF shows potential as a diagnostic biomarker.<\/jats:italic><\/jats:td>\n                      <\/jats:tr>\n                    <\/jats:tbody><\/jats:table><\/jats:table-wrap><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10067-022-06133-y","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T14:03:42Z","timestamp":1648476222000},"page":"2171-2178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Gender influence on clinical manifestations, depressive symptoms and brain-derived neurotrophic factor (BDNF) serum levels in patients affected by fibromyalgia"],"prefix":"10.1007","volume":"41","author":[{"given":"Cristina","family":"Iannuccelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Lucchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Gioia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Dolcini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jole","family":"Rabasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Venditto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ioppolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valter","family":"Santilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Di Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"issue":"15","key":"6133_CR1","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2014.3266","volume":"311","author":"DJ Clauw","year":"2014","unstructured":"Clauw DJ (2014) Fibromyalgia: a clinical review. JAMA 311(15):1547\u20131555","journal-title":"JAMA"},{"issue":"8","key":"6133_CR2","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1089\/jwh.2017.6622","volume":"27","author":"CA Arout","year":"2018","unstructured":"Arout CA, Sofuoglu M, Bastian LA, Rosenheck RA (2018) Gender differences in the prevalence of fibromyalgia and in concomitant medical and psychiatric disorders: a National Veterans Health Administration Study. J Womens Health 27(8):1035\u20131044","journal-title":"J Womens Health"},{"key":"6133_CR3","doi-asserted-by":"crossref","unstructured":"Wolfe F, Walitt B, Perrot S, Rasker JJ, H\u00e4user W (2018) Fibromyalgia diagnosis and biased assessment: sex, prevalence and bias. PloS one 13(9):e0203755","DOI":"10.1371\/journal.pone.0203755"},{"issue":"4","key":"6133_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/00002508-200307000-00005","volume":"19","author":"CD Myers","year":"2003","unstructured":"Myers CD, Riley Iii JL, Robinson ME (2003) Psychosocial contributions to sex-correlated differences in pain. Clin J Pain 19(4):225\u2013232","journal-title":"Clin J Pain"},{"issue":"1","key":"6133_CR5","first-page":"R7","volume":"11","author":"T Sokka","year":"2009","unstructured":"Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F et al (2009) Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther 11(1):R7","journal-title":"Arthritis Res Ther"},{"key":"6133_CR6","doi-asserted-by":"crossref","unstructured":"Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, H\u00e4user W, Katz RL,\u00a0Mease PJ, Russell AS, Russell IJ, Walitt B (2016) Revisions to the 2010\/2011 fibromyalgia diagnostic criteria. In: Seminars in arthritis and rheumatism 46(3):319\u2013329. WB Saunders","DOI":"10.1016\/j.semarthrit.2016.08.012"},{"issue":"1","key":"6133_CR7","first-page":"3","volume":"38","author":"L Bazzichi","year":"2020","unstructured":"Bazzichi L, Giacomelli C, Consensi A, Giorgi V, Batticciotto A, Di Franco M et al (2020) One year in review 2020: fibromyalgia. Clin Exp Rheumatol 38(1):3\u20138","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 116","key":"6133_CR8","first-page":"3","volume":"37","author":"F Atzeni","year":"2019","unstructured":"Atzeni F, Talotta R, Masala IF, Giacomelli C, Conversano C, Nucera V et al (2019) One year in review 2019: fibromyalgia. Clin Exp Rheumatol 37(Suppl 116):3\u201310","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"6133_CR9","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1097\/01.psy.0000146329.63158.40","volume":"66","author":"K Thieme","year":"2004","unstructured":"Thieme K, Turk DC, Flor H (2004) Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med 66(6):837\u2013844","journal-title":"Psychosom Med"},{"key":"6133_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000388814","volume":"7","author":"S Suliman","year":"2013","unstructured":"Suliman S, Hemmings SMJ, Seedat S (2013) Brain-derived neurotrophic factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis. Front Integr Neurosci 7:55","journal-title":"Front Integr Neurosci"},{"issue":"6","key":"6133_CR11","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3109\/15622971003611319","volume":"11","author":"L Bocchio-Chiavetto","year":"2010","unstructured":"Bocchio-Chiavetto L, Bagnardi V, Zanardini R, Molteni R, Gabriela Nielsen M, Placentino A et al (2010) Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J Biol Psychiatry 11(6):763\u2013773","journal-title":"World J Biol Psychiatry"},{"issue":"8","key":"6133_CR12","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1017\/S1461145708009309","volume":"11","author":"AR Brunoni","year":"2008","unstructured":"Brunoni AR, Lopes M, Fregni F (2008) A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol 11(8):1169\u20131180","journal-title":"Int J Neuropsychopharmacol"},{"issue":"12","key":"6133_CR13","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.1523\/JNEUROSCI.19-12-05138.1999","volume":"19","author":"BJ Kerr","year":"1999","unstructured":"Kerr BJ, Bradbury EJ, Bennett DLH, Trivedi PM, Dassan P, French J et al (1999) Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord. J Neurosci 19(12):5138\u20135148","journal-title":"J Neurosci"},{"issue":"1","key":"6133_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-49403-7","volume":"9","author":"D Baumeister","year":"2019","unstructured":"Baumeister D, Eich W, Saft S, Geisel O, Hellweg R, Finn A et al (2019) No evidence for altered plasma NGF and BDNF levels in fibromyalgia patients. Sci Rep 9(1):1\u20135","journal-title":"Sci Rep"},{"key":"6133_CR15","doi-asserted-by":"publisher","unstructured":"Ribeiro VGC, Mendon\u00e7a VA, Souza ALC, Fonseca SF, Camargos ACR, Lage VKS,\u00a0Neves CDC, Santos JM, Teixeira LAC, Vieira ELM (2018) Inflammatory biomarkers responses after acute whole body vibration in fibromyalgia. Braz J Med Biol Res 51(4):e6775.\u00a0https:\/\/doi.org\/10.1590\/1414-431X20176775","DOI":"10.1590\/1414-431X20176775"},{"issue":"1","key":"6133_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/15622975.2010.545187","volume":"13","author":"BAA Bus","year":"2012","unstructured":"Bus BAA, Tendolkar I, Franke B, De Graaf J, Heijer MD, Buitelaar JK et al (2012) Serum brain-derived neurotrophic factor: determinants and relationship with depressive symptoms in a community population of middle-aged and elderly people. World J Biol Psychiatry 13(1):39\u201347","journal-title":"World J Biol Psychiatry"},{"issue":"4","key":"6133_CR17","doi-asserted-by":"publisher","first-page":"R120","DOI":"10.1186\/ar2783","volume":"11","author":"RM Bennett","year":"2009","unstructured":"Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL (2009) The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis res Ther 11(4):R120","journal-title":"Arthritis res Ther"},{"key":"6133_CR18","unstructured":"Sica C, Ghisi M (2007) The Italian versions of the Beck Anxiety Inventory and the Beck Depression Inventory-II: psychometric properties and discriminant power. In: Lange MA (ed)\u00a0Leading-edge psychological tests and testing research. Nova Science Publishers,\u00a0pp 27\u201350"},{"issue":"7","key":"6133_CR19","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jpsychires.2006.02.007","volume":"41","author":"C Laske","year":"2007","unstructured":"Laske C, Stransky E, Eschweiler GW, Klein R, Wittorf A, Leyhe T et al (2007) Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants. J Psychiatr Res 41(7):600\u2013605","journal-title":"J Psychiatr Res"},{"issue":"2","key":"6133_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s11926-001-0008-3","volume":"3","author":"MB Yunus","year":"2001","unstructured":"Yunus MB (2001) The role of gender in fibromyalgia syndrome. Curr Rheumatol Rep 3(2):128\u2013134","journal-title":"Curr Rheumatol Rep"},{"issue":"Suppl 116","key":"6133_CR21","first-page":"90","volume":"37","author":"W H\u00e4user","year":"2019","unstructured":"H\u00e4user W, Sarzi-Puttini P, Fitzcharles M-A (2019) Fibromyalgia syndrome: under-, over-and misdiagnosis. Clin Exp Rheumatol 37(Suppl 116):90\u201397","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"6133_CR22","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1111\/j.1526-4637.2012.01523.x","volume":"13","author":"AM Castro-Sanchez","year":"2012","unstructured":"Castro-Sanchez AM, Mataran-Penarrocha GA, Lopez-Rodriguez MM, Lara-Palomo IC, Arendt-Nielsen L, Fern\u00e1ndez-de-las-Pe\u00f1as C (2012) Gender differences in pain severity, disability, depression, and widespread pressure pain sensitivity in patients with fibromyalgia syndrome without comorbid conditions. Pain med 13(12):1639\u20131647","journal-title":"Pain med"},{"key":"6133_CR23","doi-asserted-by":"publisher","unstructured":"Segura-Jim\u00e9nez V, Est\u00e9vez-L\u00f3pez F, Soriano-Maldonado A, \u00c1lvarez-Gallardo IC, Delgado-Fern\u00e1ndez M, Ruiz JR,\u00a0Aparicio VA (2016) Gender differences in symptoms, health-related quality of life, sleep quality, mental health, cognitive performance, pain-cognition, and positive health in Spanish fibromyalgia individuals: the Al-Andalus Project. Pain Res. Manag 2016:14.\u00a0https:\/\/doi.org\/10.1155\/2016\/5135176","DOI":"10.1155\/2016\/5135176"},{"issue":"8","key":"6133_CR24","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s00296-019-04323-7","volume":"39","author":"S Ahmed","year":"2019","unstructured":"Ahmed S, Aggarwal A, Lawrence A (2019) Performance of the American College of Rheumatology 2016 criteria for fibromyalgia in a referral care setting. Rheumatol Int 39(8):1397\u20131403","journal-title":"Rheumatol Int"},{"issue":"2","key":"6133_CR25","first-page":"485","volume":"27","author":"MB Yunus","year":"2000","unstructured":"Yunus MB, Inanici F, Aldag JC, Mangold RF (2000) Fibromyalgia in men: comparison of clinical features with women. J Rheumatol 27(2):485","journal-title":"J Rheumatol"},{"issue":"4","key":"6133_CR26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1177\/1557988312436872","volume":"6","author":"VA Aparicio","year":"2012","unstructured":"Aparicio VA, Ortega FB, Carbonell-Baeza A, Femia P, Tercedor P, Ruiz JR et al (2012) Are there gender differences in quality of life and symptomatology between fibromyalgia patients? Am J Mens Health 6(4):314\u2013319","journal-title":"Am J Mens Health"},{"issue":"3","key":"6133_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1300\/J094v13n03_03","volume":"13","author":"N Kurtze","year":"2005","unstructured":"Kurtze N, Svebak S (2005) A county population of males given the diagnosis of fibromyalgia syndrome\u2013comparison with fibromyalgia syndrome females regarding pain, fatigue, anxiety, and depression: the nord-tr\u00f8ndelag health study [The HUNT Study]. J Musculoskelet Pain 13(3):11\u201318","journal-title":"J Musculoskelet Pain"},{"issue":"4","key":"6133_CR28","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1177\/1557988317753242","volume":"12","author":"D Muraleetharan","year":"2018","unstructured":"Muraleetharan D, Fadich A, Stephenson C, Garney W (2018) Understanding the impact of fibromyalgia on men: findings from a nationwide survey. Am J Mens Health 12(4):952\u2013960","journal-title":"Am J Mens Health"},{"issue":"3","key":"6133_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.pneurobio.2008.04.004","volume":"85","author":"A Merighi","year":"2008","unstructured":"Merighi A, Salio C, Ghirri A, Lossi L, Ferrini F, Betelli C et al (2008) BDNF as a pain modulator. Prog Neurobiol 85(3):297\u2013317","journal-title":"Prog Neurobiol"},{"issue":"3","key":"6133_CR30","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.celrep.2019.06.054","volume":"28","author":"Z-H Wang","year":"2019","unstructured":"Wang Z-H, Xiang J, Liu X, Yu SP, Manfredsson FP, Sandoval IM et al (2019) Deficiency in BDNF\/TrkB neurotrophic activity stimulates \u03b4-secretase by upregulating C\/EBP\u03b2 in Alzheimer\u2019s disease. Cell rep 28(3):655\u2013669","journal-title":"Cell rep"},{"issue":"2","key":"6133_CR31","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/jnc.14034","volume":"142","author":"SM Nigam","year":"2017","unstructured":"Nigam SM, Xu S, Kritikou JS, Marosi K, Brodin L, Mattson MP (2017) Exercise and BDNF reduce A\u03b2 production by enhancing \u03b1-secretase processing of APP. J Neurochem 142(2):286\u2013296","journal-title":"J Neurochem"},{"key":"6133_CR32","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3389\/fneur.2019.00515","volume":"10","author":"Y Jin","year":"2019","unstructured":"Jin Y, Sun LH, Yang W, Cui RJ, Xu SB (2019) The role of BDNF in the neuroimmune axis regulation of mood disorders. Front Neurol 10:515","journal-title":"Front Neurol"},{"key":"6133_CR33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bbi.2018.09.018","volume":"75","author":"DS Albrecht","year":"2019","unstructured":"Albrecht DS, Forsberg A, Sandstr\u00f6m A, Bergan C, Kadetoff D, Protsenko E et al (2019) Brain glial activation in fibromyalgia\u2013a multi-site positron emission tomography investigation. Brain Behav Immun 75:72\u201383","journal-title":"Brain Behav Immun"},{"key":"6133_CR34","doi-asserted-by":"crossref","unstructured":"Fasolino A, Di Stefano G, Leone C, Galosi E, Gioia C, Lucchino B,\u00a0Terracciano A, Di Franco M, Cruccu G, Truini A (2020) Small-fibre pathology has no impact on somatosensory system function in patients with fibromyalgia. Pain\u00a0161(10):2385\u20132393","DOI":"10.1097\/j.pain.0000000000001920"},{"issue":"4","key":"6133_CR35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1517\/14728222.2014.994506","volume":"19","author":"J Nijs","year":"2015","unstructured":"Nijs J, Meeus M, Versijpt J, Moens M, Bos I, Knaepen K et al (2015) Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target? Expert Opin Ther Targets 19(4):565\u2013576","journal-title":"Expert Opin Ther Targets"},{"key":"6133_CR36","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.2741\/3598","volume":"14","author":"V Raison","year":"2009","unstructured":"Raison V (2009) Neurobiology of depression, fibromyalgia and neuropathic pain. Front Biosci 14:5291\u20135338","journal-title":"Front Biosci"},{"key":"6133_CR37","doi-asserted-by":"publisher","unstructured":"Alves CFdS, Caumo W, Silvestri JM, Zortea M, Santos VSd, Cardoso DF, Regner A, Souza AHd, Simon D\u00a0(2020) Pain catastrophizing is associated with the Val66Met polymorphism of the brain-derived neurotrophic factor in fibromyalgia. Adv Rheumatol 60. https:\/\/doi.org\/10.1186\/s42358-020-00141-9","DOI":"10.1186\/s42358-020-00141-9"},{"key":"6133_CR38","doi-asserted-by":"publisher","first-page":"174480691664678","DOI":"10.1177\/1744806916646783","volume":"12","author":"E Generaal","year":"2016","unstructured":"Generaal E, Milaneschi Y, Jansen R, Elzinga BM, Dekker J, Penninx BWJH (2016) The brain-derived neurotrophic factor pathway, life stress, and chronic multi-site musculoskeletal pain. Mol Pain 12:1744806916646783","journal-title":"Mol Pain"},{"issue":"1","key":"6133_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-45976-5","volume":"9","author":"AK Gejl","year":"2019","unstructured":"Gejl AK, Enevold C, Bugge A, Andersen MS, Nielsen CH, Andersen LB (2019) Associations between serum and plasma brain-derived neurotrophic factor and influence of storage time and centrifugation strategy. Sci Rep 9(1):1\u20139","journal-title":"Sci Rep"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06133-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06133-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06133-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T07:09:01Z","timestamp":1657955341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06133-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["6133"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06133-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,28]]},"assertion":[{"value":"22 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Missing Open Access funding information has been added in the Funding Note.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}